Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap

302.5000 -6.85 (-2.21%)

NSE Aug 04, 2025 15:31 PM

59.21% Gain from 52W Low

Volume: 25,076

Indoco Remedies Ltd.

10 Mar 2025

302.50

-2.21%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Indoco''s Clinical Research Organisation - AnaCipher completes US FDA inspection.

More from Indoco Remedies Ltd.

Recommended

Market closes higher, Marico's revenue grows 23.3% YoY to Rs 3,259 crore in Q1

Trendlyne Marketwatch | 04 Aug 2025, 03:58PM

IPO calendar fills up: 12 new issues, and 12 listings this week

| 04 Aug 2025, 03:44PM

Earnings Call Transcript - Q4FY20 for Indoco Remedies